226 related articles for article (PubMed ID: 26917061)
1. One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors?
Glass M; Govindpani K; Furkert DP; Hurst DP; Reggio PH; Flanagan JU
Trends Pharmacol Sci; 2016 May; 37(5):353-363. PubMed ID: 26917061
[TBL] [Abstract][Full Text] [Related]
2. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.
Floresta G; Apirakkan O; Rescifina A; Abbate V
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200181
[TBL] [Abstract][Full Text] [Related]
3. New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.
Nimczick M; Decker M
ChemMedChem; 2015 May; 10(5):773-86. PubMed ID: 25820617
[TBL] [Abstract][Full Text] [Related]
4. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.
Krishna Kumar K; Shalev-Benami M; Robertson MJ; Hu H; Banister SD; Hollingsworth SA; Latorraca NR; Kato HE; Hilger D; Maeda S; Weis WI; Farrens DL; Dror RO; Malhotra SV; Kobilka BK; Skiniotis G
Cell; 2019 Jan; 176(3):448-458.e12. PubMed ID: 30639101
[TBL] [Abstract][Full Text] [Related]
5. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
Fay JF; Farrens DL
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
Grey J; Terry P; Higgs S
Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for ligand modulation of the cannabinoid CB
Ramesh K; Rosenbaum DM
Br J Pharmacol; 2022 Jul; 179(14):3487-3495. PubMed ID: 34265078
[TBL] [Abstract][Full Text] [Related]
8. Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.
Mallipeddi S; Janero DR; Zvonok N; Makriyannis A
Biochem Pharmacol; 2017 Mar; 128():1-11. PubMed ID: 27890725
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
Manning JJ; Green HM; Glass M; Finlay DB
Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272
[TBL] [Abstract][Full Text] [Related]
10. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
Leo LM; Abood ME
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
[TBL] [Abstract][Full Text] [Related]
11. Development of Yin-Yang ligand for cannabinoid receptors.
Qiu Y; Zhao Y; Hu T; Yang M; Li F; Li C; Gu W; Yang X; Zhao S; Tao H
Bioorg Chem; 2023 Apr; 133():106377. PubMed ID: 36731294
[TBL] [Abstract][Full Text] [Related]
12. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
13. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
Pertwee RG; Howlett AC; Abood ME; Alexander SP; Di Marzo V; Elphick MR; Greasley PJ; Hansen HS; Kunos G; Mackie K; Mechoulam R; Ross RA
Pharmacol Rev; 2010 Dec; 62(4):588-631. PubMed ID: 21079038
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure.
Huang G; Pemp D; Stadtmüller P; Nimczick M; Heilmann J; Decker M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4209-14. PubMed ID: 25096297
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.
Zhang Y; Gilliam A; Maitra R; Damaj MI; Tajuba JM; Seltzman HH; Thomas BF
J Med Chem; 2010 Oct; 53(19):7048-60. PubMed ID: 20845959
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB₂R selective benzimidazoles reveal unexpected intrinsic properties.
Nimczick M; Pemp D; Darras FH; Chen X; Heilmann J; Decker M
Bioorg Med Chem; 2014 Aug; 22(15):3938-46. PubMed ID: 24984935
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of agonist-bound human cannabinoid receptor CB
Hua T; Vemuri K; Nikas SP; Laprairie RB; Wu Y; Qu L; Pu M; Korde A; Jiang S; Ho JH; Han GW; Ding K; Li X; Liu H; Hanson MA; Zhao S; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Nature; 2017 Jul; 547(7664):468-471. PubMed ID: 28678776
[TBL] [Abstract][Full Text] [Related]
18. Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55.
Kotsikorou E; Lynch DL; Abood ME; Reggio PH
Chem Phys Lipids; 2011 Feb; 164(2):131-43. PubMed ID: 21185816
[TBL] [Abstract][Full Text] [Related]
19. Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.
Jakowiecki J; Filipek S
J Chem Inf Model; 2016 Dec; 56(12):2457-2466. PubMed ID: 27966915
[TBL] [Abstract][Full Text] [Related]
20. Translational potential of allosteric modulators targeting the cannabinoid CB
Lu D; Immadi SS; Wu Z; Kendall DA
Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
